Global life sciences company Pressure BioSciences Inc. (OTCQB: PBIO) this morning announced that Richard T. Schumacher, the company’s president and CEO, will be hosting a webinar update and live Q&A session for investors today at 3:00 pm EDT. Per the update, the webinar will include discussions on enhancements made to products in PBIO’s core Research Products & Services business segment, the company’s new field salesforce, its acquisition of the assets of BaroFold Corporation and the issuance of patents related to the company’s cutting-edge Ultra Shear Technology (“UST”) platform. Schumacher is also expected to offer a brief outlook for the 2018 fiscal year. To view the webinar, interested parties should visit www.RedChip.com.
To view the full press release, visit http://ibn.fm/MstF9
About Pressure BioSciences Inc.
Pressure BioSciences Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. For more information, visit the company’s website at www.PressureBiosciences.com
About MissionIRNewsBreaks
MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.
MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]
Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html
